KTC1101 is an orally bioavailable pan-phosphoinositide 3-kinase (PI3K) inhibitor that suppresses tumor cell proliferation and modulates the tumor microenvironment. It demonstrates anti-tumor activity in preclinical models by inhibiting downstream AKT and mTOR phosphorylation, making it a useful tool for oncology research in both in vitro and in vivo settings.
Molekulargewicht:
476.48
Reinheit:
98.75% (May vary between batches)
CAS Nummer:
[2764833-47-6]
Formel:
C21H26F2N8O3
Target-Kategorie:
mTOR,Akt,PI3K
Anwendungsbeschreibung:
Solubility: DMSO:20 mg/mL (41.97 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
